21st August 2018: A new chapter in the provision of advanced cancer care in the North-East of England has started with the official opening of the Rutherford Cancer Centre North East.
8th August 2018: The provision of advanced cancer treatment in the South of England passed a key milestone today with the arrival of the first high energy proton beam therapy system in the region.
7th August 2018: The first patient to be treated with high energy proton beam therapy for breast cancer in the UK commenced treatment this week at the Rutherford Cancer Centre South Wales.
11th April 2018: Proton Partners International announced today it has treated the first patient in the UK with high energy proton beam therapy.
20th March 2018: Proton Partners International has been granted formal technical and regulatory approval from Healthcare Inspectorate Wales to begin treating patients with proton beam therapy at its Rutherford Cancer Centre in Wales.
12th March 2018: IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three new contracts with Proton Partners International, to install three Proteus®ONE* compact proton therapy solutions across the UK.
7th March 2018: Wales has shown ‘outstanding’ vision in helping to develop innovative proton beam therapy services for cancer patients.
22nd February 2018: Proton Partners International and Ion Beam Applications (IBA) Group, the world’s leading developers of high energy proton beam therapy centres and systems, have officially completed testing on the UK’s first high energy proton beam machine, the Proteus®ONE.
6th February 2018: The first proton beam therapy system to be installed in the North-East of England was delivered today by Proton Partners International Ltd.
Proton Partners International has announced today it is to name its clinics The Rutherford Cancer Centres.
The Rutherford Cancer Centres will offer patients a comprehensive range of cancer treatments and, from 2018, will be the first in the UK to offer high energy proton beam therapy.
The oncology centres have been named to reflect the renowned scientist Ernest Rutherford’s contribution in identifying and naming the proton in 1911.
Three centres are currently under development, in Newport, South Wales, Bomarsund, Northumberland and Reading, Berkshire. The Rutherford Cancer Centre, South Wales is nearing completion and will offer chemotherapy, radiotherapy and imaging via the latest planning and treatment technologies. Positron emission tomography–computed tomography (PET-CT) will be available in the second half of this year and proton beam therapy will be available at the centre from early 2018.
Treatment at The Rutherford Cancer Centres will be available to medically-insured private patients, self-paying patients and patients referred by the NHS.
Professor Gordon McVie, chairman of Proton Partners International, said: “We’re delighted to announce the creation of The Rutherford Cancer Centres.
“Proton Partners International is committed to transforming cancer care in the UK. The Rutherford name is synonymous with a major breakthrough in cancer treatment and therefore we felt that this was a fitting identity for our treatment centres.
“With cancer on the rise, there is a growing need for patients to be offered a holistic and sophisticated level of cancer care. Patients at The Rutherford Cancer Centres will have access to a wide range of cancer services and a treatment plan will be implemented on an individual basis.”
Mike Moran, chief executive officer of Proton Partners International, said: “We are working with the world’s leading technology partners to ensure that our centres are equipped with the latest cancer technology.
“Our centres will have the capacity to treat 500 unique patients a year. We will also network our centres to ensure the data they will provide can play a significant role in cancer research. We are committed to undertaking a genomics programme which will collate, analyse and distribute data through our research facility at the Life Sciences Accelerator centre in Liverpool.”